Share this post on:

Product Name :
Rifabutin

Search keywords :
Rifabutin

drugId :
null

Target Vo:
Bacterial DNA-directed RNA polymerase

Target Vo Short Name :
RNAP

Moa_Name:
Bacterial DNA-directed RNA polymerase inhibitors

First Approval Country :
United States

First Approval Date Filter:
1992

Origin Company_Name :
Pfizer Inc

Active Company_Name :
BioVersys AG

Active Indication_Name:
Tuberculosis, Multidrug-Resistant

In Active Indication_Name:
Mycobacterium Infections, Nontuberculous

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
APG5L Antibody
Acetyl-Histone H3 (Lys4) Antibody
HDAC10 Antibody: HDAC10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to HDAC10. It can be used for WB,ICC,IP assays with tag free, in the background of Human.

Share this post on:

Author: Betaine hydrochloride